Annual Cash & Cash Equivalents
$17.15 M
-$6.43 M-27.26%
December 31, 2022
Summary
- As of February 10, 2025, AXLA annual cash & cash equivalents is $17.15 million, with the most recent change of -$6.43 million (-27.26%) on December 31, 2022.
- During the last 3 years, AXLA annual cash & cash equivalents has fallen by -$74.91 million (-81.37%).
- AXLA annual cash & cash equivalents is now -81.37% below its all-time high of $92.05 million, reached on December 31, 2019.
Performance
AXLA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.88 M
-$3.66 M-29.15%
June 30, 2023
Summary
- As of February 10, 2025, AXLA quarterly cash and cash equivalents is $8.88 million, with the most recent change of -$3.66 million (-29.15%) on June 30, 2023.
- Over the past year, AXLA quarterly cash and cash equivalents has dropped by -$25.19 million (-73.93%).
- AXLA quarterly cash and cash equivalents is now -92.68% below its all-time high of $121.33 million, reached on June 30, 2020.
Performance
AXLA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AXLA Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.3% | -73.9% |
3 y3 years | -81.4% | -92.7% |
5 y5 years | -63.4% | - |
AXLA Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.3% | at low | -80.3% | at low |
5 y | 5-year | -81.4% | at low | -92.7% | at low |
alltime | all time | -81.4% | at low | -92.7% | at low |
Axcella Health Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $8.88 M(-29.2%) |
Mar 2023 | - | $12.54 M(-26.9%) |
Dec 2022 | $17.15 M(-27.3%) | $17.15 M(-32.6%) |
Sep 2022 | - | $25.43 M(-25.4%) |
Jun 2022 | - | $34.08 M(-24.6%) |
Mar 2022 | - | $45.19 M(+91.7%) |
Dec 2021 | $23.57 M(-67.1%) | $23.57 M(-9.6%) |
Sep 2021 | - | $26.09 M(-23.1%) |
Jun 2021 | - | $33.94 M(-21.2%) |
Mar 2021 | - | $43.05 M(-39.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $71.59 M(-22.2%) | $71.59 M(-37.2%) |
Sep 2020 | - | $114.06 M(-6.0%) |
Jun 2020 | - | $121.33 M(+60.6%) |
Mar 2020 | - | $75.52 M(-18.0%) |
Dec 2019 | $92.05 M(+15.8%) | $92.05 M(-12.6%) |
Sep 2019 | - | $105.36 M(-10.6%) |
Jun 2019 | - | $117.91 M(+76.6%) |
Mar 2019 | - | $66.77 M(-16.0%) |
Dec 2018 | $79.47 M(+69.7%) | $79.47 M |
Dec 2017 | $46.82 M | - |
FAQ
- What is Axcella Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Axcella Health?
- What is Axcella Health annual cash & cash equivalents year-on-year change?
- What is Axcella Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Axcella Health?
- What is Axcella Health quarterly cash and cash equivalents year-on-year change?
What is Axcella Health annual cash & cash equivalents?
The current annual cash & cash equivalents of AXLA is $17.15 M
What is the all time high annual cash & cash equivalents for Axcella Health?
Axcella Health all-time high annual cash & cash equivalents is $92.05 M
What is Axcella Health annual cash & cash equivalents year-on-year change?
Over the past year, AXLA annual cash & cash equivalents has changed by -$6.43 M (-27.26%)
What is Axcella Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AXLA is $8.88 M
What is the all time high quarterly cash and cash equivalents for Axcella Health?
Axcella Health all-time high quarterly cash and cash equivalents is $121.33 M
What is Axcella Health quarterly cash and cash equivalents year-on-year change?
Over the past year, AXLA quarterly cash and cash equivalents has changed by -$25.19 M (-73.93%)